Work

Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden

Year: 2013

Type: article

Source: Value in Health

DOI: 10.1016/j.jval.2013.08.1272

Authors: N. Begum, B. Van Hout, S. Thurston, O. Schoeman, A. Fraschke, F.W.A. Verheugt

Institution: Radboud University Medical Center

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2147679072

FWCI:

Cites:

Cited by:

Related to: 10